ARMO Biosciences, Inc

Arcus Biosciences, Inc., based in Hayward, California, is dedicated to advancing cancer treatment through the development of innovative combination therapies. The company focuses on creating best-in-class therapies, leveraging differentiated small molecules and antibodies for optimized combinability to ultimately help cure cancer. With a strong emphasis on scientific collaboration, Arcus is actively engaged in global clinical trials to hasten the delivery of new medicines to patients. Their pipeline includes promising candidates such as anti-TIGIT therapy domvanalimab and anti-PD-1 therapy zimberelimab, reflecting their commitment to pioneering cancer treatment solutions. Generated from the website

Septerna, Inc, situated in South San Francisco, CA, is dedicated to pioneering a new era of GPCR drug discovery. The company focuses on unlocking the full potential of G protein-coupled receptor (GPCR) drug targets to develop impactful new medicines across therapeutic areas. Powered by their proprietary Native Complex Platform™, Septerna is at the forefront of discovering innovative ways to drug GPCRs. Their industrial-scale platform is designed to unlock challenging GPCRs, leading to the development of a pipeline of oral small molecule drug candidates. Septerna boasts a world-class team of drug hunters, GPCR experts, and drug developers committed to advancing cutting-edge science. Their collaboration-driven approach and relentless focus on developing novel oral small molecule GPCR-targeted programs set them apart in the industry. Generated from the website content

Tricida, based in South San Francisco, CA, is a company that provides information on SEC.gov. With a focus on delivering comprehensive information, Tricida offers valuable insights and resources through its platform.Generated from the website